Argonaut Capacity Update April 2025: Fill/Finish

Argonaut provides aseptic fill finish services for partners in clinical through commercialization phases. We have a wide range of experience in fill finish services including biologics (e.g. mAB and proteins), small and intermediate molecules (including peptides), oligos, vaccines, along with diluents, adjuvants, and placebos.

Our current line focuses on vials, while our new line (Q1 2026) extends to cartridges and syringes. All lines are in ISO5/Grade A condition isolators, feature 100% in-line weight checks, and deliver near-zero line loss. All lines are EU Annex 1 compliant. Argonaut also provides formulation services from 200L to 800L. Argonaut facilities are located in the U.S., and we routinely provide partners with warehousing and logistics services. Learn more at www.argonautms.com.